H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $74 billion of capital under management, is pleased to announce a strategic partnership with the Barts Health NHS Trust to deliver the first applied healthcare innovation building within the newly launched Barts Life Sciences Cluster at Cavell Street in London, Whitechapel.
The partnership brings together one of the UK’s largest NHS Trusts, a global investment platform, and a specialist science and technology developer to pioneer new models of collaboration between clinicians, researchers, and industry. The 170,000 sq ft Cavell Street development will serve as a landmark project within the Cluster, marking the start of a new era for health innovation in East London, and one defined by the integration of clinical excellence and commercial capability.
Cavell Street will establish a new hub for NHS industry collaboration, enabling companies to work directly with Barts Health clinicians and researchers to shape, test, and refine next-generation technologies across MedTech, AI, digital health, and other emerging fields. The development aims to create a state-of-the-art environment for applied healthcare innovation where MedTech and life sciences organisations can co-develop, demonstrate, and validate technologies in real clinical settings in partnership with staff from The Royal London Hospital and other Barts Health hospitals.
Cavell Street aims to create a high-performance, innovation-ready ecosystem that speeds the journey from prototype to patient and enhances the UK’s capacity for NHS-embedded innovation.
Shane DeGaris, Group CEO of Barts Health NHS Trust, said: “Through the Barts Life Sciences Cluster, we are bringing clinicians, patients, industry, and academia together in new ways. This first partnership project at Cavell Street begins to turn that ambition into reality. By creating environments where innovation can be shaped directly by NHS teams and tested in real care settings, we aim to improve patient outcomes and support economic opportunity for East London.”
Jérôme Fouillé, Managing Director at H.I.G. Realty in Europe, commented: “We are delighted to partner with Barts Health on the Cluster’s first innovation-led development. Cavell Street will create a new platform for global companies to collaborate directly with NHS clinicians, reinforcing the Cluster’s position as a leading centre for applied healthcare innovation.”
Discover the latest trends and insights—explore the Business Insight Journal for up-to-date strategies and industry breakthroughs!
